Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
about
The mechanistic classification of addictive drugsHub and switches: endocannabinoid signalling in midbrain dopamine neuronsThe endocannabinoid system as an emerging target of pharmacotherapyMarijuana and cannabinoid regulation of brain reward circuitsTo Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-MakingCocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental AreaBrain Reward Circuits in Morphine AddictionPresynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptorsDisruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abusePresynaptic GABAA receptors facilitate GABAergic transmission to dopaminergic neurons in the ventral tegmental area of young ratsObesity: Current and potential pharmacotherapeutics and targets.Two independent forms of activity-dependent potentiation regulate electrical transmission at mixed synapses on the Mauthner cell.Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens.Endocannabinoids promote cocaine-induced impulsivity and its rapid dopaminergic correlatesFeeding induced by cannabinoids is mediated independently of the melanocortin systemEndocannabinoids and striatal function: implications for addiction-related behavioursRelease of endogenous cannabinoids from ventral tegmental area dopamine neurons and the modulation of synaptic processesLocalization of CXCR4 in the forebrain of the adult rat.The role of cannabinoid transmission in emotional memory formation: implications for addiction and schizophreniaThe K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.GABAergic and glutamatergic efferents of the mouse ventral tegmental area.Afferent-specific AMPA receptor subunit composition and regulation of synaptic plasticity in midbrain dopamine neurons by abused drugs.Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodelingDrugs of abuse and increased risk of psychosis development.Cannabinoid modulation of drug reward and the implications of marijuana legalizationEmerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease.Endocannabinoid signaling in midbrain dopamine neurons: more than physiology?Pretreatment with Δ9-tetrahydrocannabinol (THC) increases cocaine-stimulated activity in adolescent but not adult male ratsBehavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2.In vivo neurochemical monitoring using benzoyl chloride derivatization and liquid chromatography-mass spectrometry.Prenatal tetrahydrocannabinol (THC) alters cognitive function and amphetamine response from weaning to adulthood in the ratNeuron-type-specific signals for reward and punishment in the ventral tegmental areaEffect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats.Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis usersChronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdalaCannabinoid receptor 1-expressing neurons in the nucleus accumbens.Cannabinoids and value-based decision making: implications for neurodegenerative disorders.Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area.Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism.
P2860
Q21090144-954B5D17-4098-4856-B33A-61472D820003Q24623244-288152FC-034B-4FDF-B4A5-A8E84B70A71FQ24648473-3BD83FDE-5EDB-4E34-B721-AD711544EE15Q24671514-44783435-9510-4868-A627-C4E50539A915Q26770739-74A47284-F099-4CA8-9828-D6B91A7F1684Q27320220-8F33E116-ADD8-4EEA-8DE1-5E16E954E5C6Q28075628-7B9E48CD-D55C-4E9D-9B40-D17A6C50A847Q28078759-5002902A-6261-4316-91A0-7DECC3BD3542Q28244889-D35CE84E-7C86-43F0-A6F5-B09103C88FC5Q28297001-3FAB7DF9-E1E4-46C4-9C9D-049DFCDEA896Q28581680-DB15C009-BC54-4DE9-A5E4-4B60B4D2D976Q30243992-1C50C148-8738-4F43-880A-C012EDE54EA6Q30434673-C2D9010D-B348-468D-A78D-D18A8912C8C3Q30499463-C8752524-3D3A-4288-B009-391F49FCF189Q30573498-624B2483-A3D7-4B1C-97CC-C5DBCF53457DQ33336552-6A5383F9-92E1-4374-B1C8-3E868E7E579AQ33583792-F7CAA389-3BFE-4242-8A66-6ED711227D98Q33599036-9E437DFB-875C-4BD2-A098-1AFFF2DF11B7Q33680544-4C4DF15B-0F0A-4674-8553-1140E90AAA7BQ33820114-4D6EE4E0-1528-4A89-B688-98F31A5BED10Q33908169-97B0C7CF-9E5E-4C24-A862-A7E4196CDC65Q33934271-4F719F22-5535-4F0F-8966-BEBF1DB94D5FQ33975305-89A7D851-8C90-4303-BC54-E32E1373372EQ34166000-295EDBA8-66A7-4A03-B5E0-CA1779CF833CQ34290364-3D65C390-C7B8-4958-9C07-0718F4DE5D39Q34451442-016F707B-E2E1-41B0-8E5D-C85B4E2016ACQ34643934-018AC1BE-3B0B-433C-9EB4-717A0F0C9381Q34967151-6BBDC3F1-E19E-481D-B383-341D2E976319Q35624218-25B374BA-8854-4DC3-8830-AD7BE85EF57AQ35626928-64DC0FC4-20E1-423C-8F0E-3AC5E88A34CAQ35675204-E54277F6-2352-4F2F-85C7-AC701C26F0B7Q35713119-50E0E36F-7BB4-4ED4-A47A-187DBD1D0B8DQ35729983-2CAD1FCE-EAD9-4F75-932D-6F6DB152831EQ36201313-CD52A722-901A-4CD9-8130-C277D0EFB2EDQ36234299-44FAC399-BF3A-4391-B1B7-AAEF2D4DAC79Q36253945-B7E0BFFD-A541-4A80-92EB-F19E55C02EE2Q36342981-F6CDA275-A604-495F-AA83-5711252F293BQ36393644-859FCF3B-C6AC-4B20-9336-4F444B2E9237Q36452302-1BAA031A-8D9B-48E4-B1D7-232E08BCCE02Q36457393-5AB4C83D-5C94-435F-91CC-635EB82ECDC1
P2860
Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
@en
Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
@nl
type
label
Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
@en
Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
@nl
prefLabel
Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
@en
Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
@nl
P2093
P2860
P1476
Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
@en
P2093
Bela Szabo
Ilka Wallmichrath
Sabine Siemes
P2860
P304
P356
10.1046/J.1460-9568.2002.02041.X
P407
P577
2002-06-01T00:00:00Z